Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions

Monoclonal therapeutic antibodies have revolutionized the treatment of cancer and other diseases. Fc engineering aims to enhance the effector functions or half-life of therapeutic antibodies by modifying their Fc regions. Recent advances in the Fc engineering of modern therapeutic antibodies can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdeldaim, Dalia T., Schindowski, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610324/
https://www.ncbi.nlm.nih.gov/pubmed/37896162
http://dx.doi.org/10.3390/pharmaceutics15102402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610324/
https://www.ncbi.nlm.nih.gov/pubmed/37896162
http://dx.doi.org/10.3390/pharmaceutics15102402

Ejemplares similares